Journal article
Induction of protective CD4 T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses
K Kedzierska, JM Curtis, SA Valkenburg, LA Hatton, H Kiu, PC Doherty, L Kedzierski
Plos One | PUBLIC LIBRARY SCIENCE | Published : 2012
Abstract
The available evidence suggests that protective immunity to Leishmania is achieved by priming the CD4+ Th1 response. Therefore, we utilised a reverse genetics strategy to generate influenza A viruses to deliver an immunogenic Leishmania peptide. The single, immunodominant Leishmania-specific LACK158-173 CD4+ peptide was engineered into the neuraminidase stalk of H1N1 and H3N2 influenza A viruses. These recombinant viruses were used to vaccinate susceptible BALB/c mice to determine whether the resultant LACK158-173-specific CD4+ T cell responses protected against live L. major infection. We show that vaccination with influenza-LACK158-173 triggers LACK158-173-specific Th1-biased CD4+ T cell r..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the Australian National Health and Medical Research Council, (Project Grant 406631 and Program Grant 406601), NHMRC Independent Research Institutes Infrastructure Support Scheme grant #361646, and Victorian State Government Operational Infrastructure Support grant. KK is an NHMRC RD Wright Research Fellow. LAH and HK are recipients of an NHMRC Biomedical Postgraduate Research Scholarship, and SAV is a recipient of the Australian Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.